Navigation Links
Concentric Named Professional Agency of Record for Discovery Labs' SURFAXIN(R)
Date:9/3/2008

NEW YORK, Sept. 3 /PRNewswire/ -- Concentric Pharma Advertising, one of the fastest growing marketing agencies in the healthcare field, has been named agency of record by Discovery Labs for SURFAXIN(R) (lucinactant), an investigational drug being reviewed by the Food and Drug Administration for the treatment of respiratory distress syndrome (RDS) in newborns.

"We selected Concentric for this assignment because the company's strategic insight and creative vision best captured the essence of the SURFAXIN brand," said John Wilson, vice president of sales and marketing at Discovery, adding that the agency's in-depth knowledge of neonatology and acute RDS in premature infants also played a significant part in the decision.

The full-service U.S. assignment will include a wide range of activities, including corporate and product branding, positioning, and the creation of support materials geared to neonatologists, neonatal intensive care unit (NICU) nurses, respiratory therapists, hospital pharmacists, and, potentially, parents of newborns. The agency's account team will be led by Ed Mutch, account supervisor. Blake Benner, director of marketing at Discovery Labs, will manage the account on the client side.

Discovery Labs, headquartered in Warrington, Pa., is a biotechnology company developing novel surfactant replacement therapies (SRTs) with potential for application across the continuum of respiratory diseases, initially focusing on RDS in premature infants.

About Concentric

Concentric Pharma Advertising, an independent healthcare advertising and marketing firm established in 2002, is one of the fastest growing agencies in the healthcare field, enjoying double-digit revenue growth for the fourth year in a row. In the past year alone, the agency won 10 new assignments, launched a new division, expanded its senior management team, and won several awards in prestigious U.S. and global ad competitions.

Concentric offers a wid
'/>"/>

SOURCE Concentric Pharma Advertising
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
2. Concentric Wins Full-Service Professional Assignment From Biopharm Innovator Neuromed
3. Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc
4. Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US
5. IDIS Opens New American Office in Response to Industrys Growing Need for Pre-Launch Named Patient Programs
6. Integrated Project Management Named to "Inc. 5000" for Second Year : One of the Top 100 Fastest-Growing Companies in Chicago Area
7. Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
8. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
9. William F. Prendergast Named One of the Top IP Lawyers in Nanotechnology
10. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
11. Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , , QUEBEC CITY, Dec. 2 /PRNewswire-Firs...X: AEZ) (the "Company"), a global biopharmaceutica...y, today announced that the U.S. Food and Drug Adm...on for the Company,s PI3K/Akt pathway inhibitor co...f relapsed/refractory multiple myeloma. Keryx Biop...
(Date:12/2/2009)... , , HOBOKEN, N.J., Dec. 2 /PRNewswire/ ...40 percent to 45 percent of Americans diagnosed wi...tinopathy. Diabetic retinopathy, damage to the re...se of blindness in people with diabetes and is one...ct, up to 80 percent of all patients who,ve had di...
(Date:12/1/2009)... , , NEW YORK, Dec. 1 /PRNewswire/ ...search report is available in its catalogue: ,,.../www.reportlinker.com/p0164494/Chromium---Global-M...mium is primarily influenced by stainless steel, w...e markets is also important for growth of chromium...
(Date:12/1/2009)... , , PLYMOUTH, Mass., Dec. 1 /PRNewswire/...om ) announced today results from the company spon...amachandra Medical Center in Chennai, India using ...on-reconstructable Critical Limb Ischemia (CLI). S... international-associated institution based in Che...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3
...other twist on the strangeness of the nanoworld, r...and Technology (NIST) and the University of Maryla...h as silica that are quite brittle in bulk form be...sults may affect the design of future nanomachines... Kim and colleagues first demonstrated* the latest...
...CELAND, March 12 deCODE genetics,(Nasdaq: DCGN )...s for the,quarter and year ended December 31, 2007...and operating highlights will be webcast live tomo... (details below)., Net loss for the year ended De...5 million for the full year 2006. Basic and dilute...
...N JOSE, Calif., March 12 Oncolys BioPharma,Inc. (...ose, CA, USA),announced today that they have enter... to develop and commercialize throughout Asia, Tac...rus (HCV) compound, TT-033,code-named by Oncolys a...gic alliance entered into by Tacere and Oncolys in...
Other Biology Technology:Nanomaterials show unexpected strength under stress 2deCODE Genetics Announces Full-year 2007 Financial Results 2deCODE Genetics Announces Full-year 2007 Financial Results 3deCODE Genetics Announces Full-year 2007 Financial Results 4deCODE Genetics Announces Full-year 2007 Financial Results 5deCODE Genetics Announces Full-year 2007 Financial Results 6deCODE Genetics Announces Full-year 2007 Financial Results 7deCODE Genetics Announces Full-year 2007 Financial Results 8deCODE Genetics Announces Full-year 2007 Financial Results 9Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug 2Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug 3
(Date:12/1/2009)...sease, nerve cell degeneration plays a crucial rol...ibly be derived from steering the generation and/o...blished in the current issue of the renowned journ...go, neurogenesis the process of nerve cell develo...t brain. The textbooks asserted that dead nerve ce...
(Date:12/1/2009)...hnology has been awarded a U.S. Air Force Center o...arvesting and adaptive materials, and to develop t...he modern warfighter. , The $10.5 million Cente... Nanostructures and Improved Cognition (BIONIC) ce... Sandhage, professors in Georgia Tech,s School of ...
(Date:12/1/2009)... attacks by sharks can be solved with a new techni...mp they put on their victims, according to a Unive...In a method analogous to analyzing human fingerpri...ely comparing shark bites to the jaws and teeth of...ctor of the International Shark Attack File, which...
Breaking Biology News(10 mins):New source discovered for the generation of nerve cells in the brain 2Air Force Center of Excellence awarded in nanostructures and improved cognition 2Air Force Center of Excellence awarded in nanostructures and improved cognition 3Air Force Center of Excellence awarded in nanostructures and improved cognition 4New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3Traveling With Diabetes The Positive Way 55962 1Traveling With Diabetes The Positive Way 55962 2Traveling With Diabetes The Positive Way 55962 3Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 1Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 2Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 3Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 4Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 5SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 1SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 2SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 3SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 4SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 5SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 6SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 7SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 8SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 9
...ding on newly discovered genetic threads in the ri...er, a Johns Hopkins Kimmel Cancer Center team has ... those signals with a statin and an experimental a...ol-lowering lovastatin and cyclopamine killed 63 p...atory. By contrast, using either agent alone wipe...
...ct detection of base sequence in duplex nucleic ac...s Research will publish "Heteropolymeric Triplex-B...Nucleotide Polymorphisms in Human Genomic Samples"...r-reviewed, open access, online journal, PLoS ONE....elating to the assay of pathogens in samples also ...
...ntists at Rice University and pediatric specialist...new way to use Rice,s famed buckyball nanoparticle...lls. , The research appears in the Jan. 21 issue o... , All living cells defend themselves by walling...form a protective cocoon around the cell,s inner m...
Other Biology News:Statin plus cancer drug deliver combo punch to brain cancer cells 2Triplex assay used to assay duplex genomic DNA 2Buckyballs used as 'passkey' into cancer cells 2
Terrific Broth from GE Healthcare, formerly Amersham Biosciences
Mouse Anti-Human VEGF R3 / Flt-4 Monoclonal Antibody, Phycoerythrin Conjugated, Clone 54733 from R&D Systems
Goat Anti-Human Legumain Polyclonal Antibodies, from R&D Systems
Mouse Anti-Human Cystatin F Monoclonal Antibodies, 292103 from R&D Systems
Biology Products: